-
1
-
-
1542398881
-
Imatinib sensitizes CLL lymphocytes to chlorambucil
-
Aloyz, R., Grzywacz, K., Xu, Z.Y., Loignon, M., Alaoui-Jamali, M.A. Panasci, L. (2004) Imatinib sensitizes CLL lymphocytes to chlorambucil. Leukemia, 18, 409 414.
-
(2004)
Leukemia
, vol.18
, pp. 409-414
-
-
Aloyz, R.1
Grzywacz, K.2
Xu, Z.Y.3
Loignon, M.4
Alaoui-Jamali, M.A.5
Panasci, L.6
-
2
-
-
34248594725
-
Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase
-
Amrein, L., Loignon, M., Goulet, A.C., Dunn, M., Jean-Claude, B., Aloyz, R. Panasci, L. (2007) Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase. Journal of Pharmacology & Experimental Therapeutics, 321, 848 855.
-
(2007)
Journal of Pharmacology & Experimental Therapeutics
, vol.321
, pp. 848-855
-
-
Amrein, L.1
Loignon, M.2
Goulet, A.C.3
Dunn, M.4
Jean-Claude, B.5
Aloyz, R.6
Panasci, L.7
-
3
-
-
0028204418
-
Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy
-
Begleiter, A., Lee, K., Israels, L.G., Mowat, M.R. Johnston, J.B. (1994) Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy. Leukemia, 8 (Suppl. 1 S103 S106.
-
(1994)
Leukemia
, vol.8
, Issue.1
-
-
Begleiter, A.1
Lee, K.2
Israels, L.G.3
Mowat, M.R.4
Johnston, J.B.5
-
4
-
-
0030460338
-
Chlorambucil in chronic lymphocytic leukemia: Mechanism of action
-
Begleiter, A., Mowat, M., Israels, L.G. Johnston, J.B. (1996) Chlorambucil in chronic lymphocytic leukemia: mechanism of action. Leukemia & Lymphoma, 23, 187 201.
-
(1996)
Leukemia & Lymphoma
, vol.23
, pp. 187-201
-
-
Begleiter, A.1
Mowat, M.2
Israels, L.G.3
Johnston, J.B.4
-
5
-
-
0036570311
-
Homologous recombinational repair vis-a-vis chlorambucil resistance in chronic lymphocytic leukemia
-
Bello, V.E., Aloyz, R.S., Christodoulopoulos, G. Panasci, L.C. (2002) Homologous recombinational repair vis-a-vis chlorambucil resistance in chronic lymphocytic leukemia. Biochemical Pharmacology, 63, 1585 1588.
-
(2002)
Biochemical Pharmacology
, vol.63
, pp. 1585-1588
-
-
Bello, V.E.1
Aloyz, R.S.2
Christodoulopoulos, G.3
Panasci, L.C.4
-
6
-
-
0027120791
-
Re: W. R. Greco et al, Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Research, 50, 5318-5327, 1990
-
author reply 4555-4561).
-
Berenbaum, M.C. (1992) Re: W. R. Greco et al, Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Research, 50, 5318-5327, 1990. Cancer Research, 52, 4558 4560 (author reply 4555-4561).
-
(1992)
Cancer Research
, vol.52
, pp. 4558-4560
-
-
Berenbaum, M.C.1
-
7
-
-
0029990349
-
B-chronic lymphocytic leukemia: A malignancy of anti-self B cells
-
Caligaris-Cappio, F. (1996) B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood, 87, 2615 2620.
-
(1996)
Blood
, vol.87
, pp. 2615-2620
-
-
Caligaris-Cappio, F.1
-
8
-
-
0032080433
-
Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin
-
Christodoulopoulos, G., Muller, C., Salles, B., Kazmi, R. Panasci, L. (1998) Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin. Cancer Research, 58, 1789 1792.
-
(1998)
Cancer Research
, vol.58
, pp. 1789-1792
-
-
Christodoulopoulos, G.1
Muller, C.2
Salles, B.3
Kazmi, R.4
Panasci, L.5
-
9
-
-
0032766425
-
Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia
-
Christodoulopoulos, G., Malapetsa, A., Schipper, H., Golub, E., Radding, C. Panasci, L.C. (1999) Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia. Clinical Cancer Research, 5, 2178 2184.
-
(1999)
Clinical Cancer Research
, vol.5
, pp. 2178-2184
-
-
Christodoulopoulos, G.1
Malapetsa, A.2
Schipper, H.3
Golub, E.4
Radding, C.5
Panasci, L.C.6
-
10
-
-
20144385604
-
Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis
-
Contri, A., Brunati, A.M., Trentin, L., Cabrelle, A., Miorin, M., Cesaro, L., Pinna, L.A., Zambello, R., Semenzato, G. Donella-Deana, A. (2005) Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. Journal of Clinical Investigation, 115, 369 378.
-
(2005)
Journal of Clinical Investigation
, vol.115
, pp. 369-378
-
-
Contri, A.1
Brunati, A.M.2
Trentin, L.3
Cabrelle, A.4
Miorin, M.5
Cesaro, L.6
Pinna, L.A.7
Zambello, R.8
Semenzato, G.9
Donella-Deana, A.10
-
11
-
-
17144426933
-
Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukaemic cells but not in normal lymphocytes
-
Czechowska, A., Poplawski, T., Drzewoski, J. Blasiak, J. (2005) Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukaemic cells but not in normal lymphocytes. Chemical Biological Interactions, 152, 139 150.
-
(2005)
Chemical Biological Interactions
, vol.152
, pp. 139-150
-
-
Czechowska, A.1
Poplawski, T.2
Drzewoski, J.3
Blasiak, J.4
-
12
-
-
20444416724
-
Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway
-
Deriano, L., Guipaud, O., Merle-Beral, H., Binet, J.L., Ricoul, M., Potocki-Veronese, G., Favaudon, V., Maciorowski, Z., Muller, C., Salles, B., Sabatier, L. Delic, J. (2005) Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway. Blood, 105, 4776 4783.
-
(2005)
Blood
, vol.105
, pp. 4776-4783
-
-
Deriano, L.1
Guipaud, O.2
Merle-Beral, H.3
Binet, J.L.4
Ricoul, M.5
Potocki-Veronese, G.6
Favaudon, V.7
MacIorowski, Z.8
Muller, C.9
Salles, B.10
Sabatier, L.11
Delic, J.12
-
13
-
-
36148978171
-
Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells
-
Efremov, D.G., Gobessi, S. Longo, P.G. (2007) Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells. Autoimmunity Reviews, 7, 102 108.
-
(2007)
Autoimmunity Reviews
, vol.7
, pp. 102-108
-
-
Efremov, D.G.1
Gobessi, S.2
Longo, P.G.3
-
14
-
-
0032532668
-
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors
-
Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A., Allen, S.L., Schulman, P., Vinciguerra, V.P., Rai, K., Rassenti, L.Z., Kipps, T.J., Dighiero, G., Schroeder, Jr., H.W., Ferrarini, M. Chiorazzi, N. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. Journal of Clinical Investigation, 102, 1515 1525.
-
(1998)
Journal of Clinical Investigation
, vol.102
, pp. 1515-1525
-
-
Fais, F.1
Ghiotto, F.2
Hashimoto, S.3
Sellars, B.4
Valetto, A.5
Allen, S.L.6
Schulman, P.7
Vinciguerra, V.P.8
Rai, K.9
Rassenti, L.Z.10
Kipps, T.J.11
Dighiero, G.12
Schroeder Jr., H.W.13
Ferrarini, M.14
Chiorazzi, N.15
-
15
-
-
47549107231
-
Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cells
-
Fanta, S., Sonnenberg, M., Skorta, I., Duyster, J., Miething, C., Aulitzky, W.E. van der Kuip, H. (2008) Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cells. Oncogene, 27, 4380 4384.
-
(2008)
Oncogene
, vol.27
, pp. 4380-4384
-
-
Fanta, S.1
Sonnenberg, M.2
Skorta, I.3
Duyster, J.4
Miething, C.5
Aulitzky, W.E.6
Van Der Kuip, H.7
-
16
-
-
22144448593
-
Histone H2A phosphorylation in DNA double-strand break repair
-
Foster, E.R. Downs, J.A. (2005) Histone H2A phosphorylation in DNA double-strand break repair. The FEBS Journal, 272, 3231 3240.
-
(2005)
The FEBS Journal
, vol.272
, pp. 3231-3240
-
-
Foster, E.R.1
Downs, J.A.2
-
17
-
-
0034651739
-
Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells
-
Furman, R.R., Asgary, Z., Mascarenhas, J.O., Liou, H.C. Schattner, E.J. (2000) Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells. Journal of Immunology, 164, 2200 2206.
-
(2000)
Journal of Immunology
, vol.164
, pp. 2200-2206
-
-
Furman, R.R.1
Asgary, Z.2
Mascarenhas, J.O.3
Liou, H.C.4
Schattner, E.J.5
-
18
-
-
33847412872
-
ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells
-
Gobessi, S., Laurenti, L., Longo, P.G., Sica, S., Leone, G. Efremov, D.G. (2007) ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells. Blood, 109, 2032 2039.
-
(2007)
Blood
, vol.109
, pp. 2032-2039
-
-
Gobessi, S.1
Laurenti, L.2
Longo, P.G.3
Sica, S.4
Leone, G.5
Efremov, D.G.6
-
19
-
-
13944275218
-
Treatment of chronic myeloid leukemia cells with imatinib (STI571) impairs p53 accumulation in response to DNA damage
-
Goldberg, Z., Levav, Y., Krichevsky, S., Fibach, E. Haupt, Y. (2004) Treatment of chronic myeloid leukemia cells with imatinib (STI571) impairs p53 accumulation in response to DNA damage. Cell Cycle, 3, 1188 1195.
-
(2004)
Cell Cycle
, vol.3
, pp. 1188-1195
-
-
Goldberg, Z.1
Levav, Y.2
Krichevsky, S.3
Fibach, E.4
Haupt, Y.5
-
20
-
-
0023708553
-
Abl oncogene expression in non-Hodgkin lymphomas: Correlation to histological differentiation and clinical status
-
Greil, K., Gattringer, C., Fasching, B., Cleveland, J., Thaler, J., Radaskiewicz, T., Gastl, G., Huber, C., Rapp, U. Huber, H. (1988) abl oncogene expression in non-Hodgkin lymphomas: correlation to histological differentiation and clinical status. International Journal of Cancer, 42, 529 538.
-
(1988)
International Journal of Cancer
, vol.42
, pp. 529-538
-
-
Greil, K.1
Gattringer, C.2
Fasching, B.3
Cleveland, J.4
Thaler, J.5
Radaskiewicz, T.6
Gastl, G.7
Huber, C.8
Rapp, U.9
Huber, H.10
-
21
-
-
0030722666
-
Chronic lymphocytic leukaemia: The nature of the leukaemic cell
-
Hamblin, T.J. Oscier, D.G. (1997) Chronic lymphocytic leukaemia: the nature of the leukaemic cell. Blood Reviews, 11, 119 128.
-
(1997)
Blood Reviews
, vol.11
, pp. 119-128
-
-
Hamblin, T.J.1
Oscier, D.G.2
-
22
-
-
0035679122
-
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia
-
Jelinek, D.F., Tschumper, R.C., Geyer, S.M., Bone, N.D., Dewald, G.W., Hanson, C.A., Stenson, M.J., Witzig, T.E., Tefferi, A. Kay, N.E. (2001) Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. British Journal of Haematology, 115, 854 861.
-
(2001)
British Journal of Haematology
, vol.115
, pp. 854-861
-
-
Jelinek, D.F.1
Tschumper, R.C.2
Geyer, S.M.3
Bone, N.D.4
Dewald, G.W.5
Hanson, C.A.6
Stenson, M.J.7
Witzig, T.E.8
Tefferi, A.9
Kay, N.E.10
-
23
-
-
0031974526
-
Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines
-
Kitada, S., Krajewska, M., Zhang, X., Scudiero, D., Zapata, J.M., Wang, H.G., Shabaik, A., Tudor, G., Krajewski, S., Myers, T.G., Johnson, G.S., Sausville, E.A. Reed, J.C. (1998) Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. American Journal of Pathology, 152, 51 61.
-
(1998)
American Journal of Pathology
, vol.152
, pp. 51-61
-
-
Kitada, S.1
Krajewska, M.2
Zhang, X.3
Scudiero, D.4
Zapata, J.M.5
Wang, H.G.6
Shabaik, A.7
Tudor, G.8
Krajewski, S.9
Myers, T.G.10
Johnson, G.S.11
Sausville, E.A.12
Reed, J.C.13
-
24
-
-
33646757232
-
The complexity of p53 stabilization and activation
-
Lavin, M.F. Gueven, N. (2006) The complexity of p53 stabilization and activation. Cell Death & Differentiation, 13, 941 950.
-
(2006)
Cell Death & Differentiation
, vol.13
, pp. 941-950
-
-
Lavin, M.F.1
Gueven, N.2
-
25
-
-
33747873541
-
C-Abl expression in chronic lymphocytic leukemia cells: Clinical and therapeutic implications
-
Lin, K., Glenn, M.A., Harris, R.J., Duckworth, A.D., Dennett, S., Cawley, J.C., Zuzel, M. Slupsky, J.R. (2006) c-Abl expression in chronic lymphocytic leukemia cells: clinical and therapeutic implications. Cancer Research, 66, 7801 7809.
-
(2006)
Cancer Research
, vol.66
, pp. 7801-7809
-
-
Lin, K.1
Glenn, M.A.2
Harris, R.J.3
Duckworth, A.D.4
Dennett, S.5
Cawley, J.C.6
Zuzel, M.7
Slupsky, J.R.8
-
26
-
-
33947322018
-
XRCC3 depletion induces spontaneous DNA breaks and p53-dependent cell death
-
Loignon, M., Amrein, L., Dunn, M. Aloyz, R. (2007) XRCC3 depletion induces spontaneous DNA breaks and p53-dependent cell death. Cell Cycle, 6, 606 611.
-
(2007)
Cell Cycle
, vol.6
, pp. 606-611
-
-
Loignon, M.1
Amrein, L.2
Dunn, M.3
Aloyz, R.4
-
27
-
-
51849140016
-
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCELtrade mark), a multi-targeted kinase inhibitor
-
doi:).
-
Luo, F.R., Barrett, Y.C., Yang, Z., Camuso, A., McGlinchey, K., Wen, M.L., Smykla, R., Fager, K., Wild, R., Palme, H., Galbraith, S., Blackwood-Chirchir, A. Lee, F.Y. (2008) Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCELtrade mark), a multi-targeted kinase inhibitor. Cancer Chemotherapy & Pharmacology, 36, 1357 1364 (doi :).
-
(2008)
Cancer Chemotherapy & Pharmacology
, vol.36
, pp. 1357-1364
-
-
Luo, F.R.1
Barrett, Y.C.2
Yang, Z.3
Camuso, A.4
McGlinchey, K.5
Wen, M.L.6
Smykla, R.7
Fager, K.8
Wild, R.9
Palme, H.10
Galbraith, S.11
Blackwood-Chirchir, A.12
Lee, F.Y.13
-
28
-
-
0041663417
-
Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization
-
Master, Z., Tran, J., Bishnoi, A., Chen, S.H., Ebos, J.M., Van Slyke, P., Kerbel, R.S. Dumont, D.J. (2003) Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization. Journal of Biological Chemistry, 278, 30170 30179.
-
(2003)
Journal of Biological Chemistry
, vol.278
, pp. 30170-30179
-
-
Master, Z.1
Tran, J.2
Bishnoi, A.3
Chen, S.H.4
Ebos, J.M.5
Van Slyke, P.6
Kerbel, R.S.7
Dumont, D.J.8
-
29
-
-
34548086185
-
Src kinase inhibitors induce apoptosis and mediate cell cycle arrest in lymphoma cells
-
Nowak, D., Boehrer, S., Hochmuth, S., Trepohl, B., Hofmann, W., Hoelzer, D., Hofmann, W.K., Mitrou, P.S., Ruthardt, M. Chow, K.U. (2007) Src kinase inhibitors induce apoptosis and mediate cell cycle arrest in lymphoma cells. Anti-Cancer Drugs, 18, 981 995.
-
(2007)
Anti-Cancer Drugs
, vol.18
, pp. 981-995
-
-
Nowak, D.1
Boehrer, S.2
Hochmuth, S.3
Trepohl, B.4
Hofmann, W.5
Hoelzer, D.6
Hofmann, W.K.7
Mitrou, P.S.8
Ruthardt, M.9
Chow, K.U.10
-
30
-
-
34250319358
-
Identification and functional signature of genes regulated by structurally different ABL kinase inhibitors
-
Nunoda, K., Tauchi, T., Takaku, T., Okabe, S., Akahane, D., Sashida, G., Ohyashiki, J.H. Ohyashiki, K. (2007) Identification and functional signature of genes regulated by structurally different ABL kinase inhibitors. Oncogene, 26, 4179 4188.
-
(2007)
Oncogene
, vol.26
, pp. 4179-4188
-
-
Nunoda, K.1
Tauchi, T.2
Takaku, T.3
Okabe, S.4
Akahane, D.5
Sashida, G.6
Ohyashiki, J.H.7
Ohyashiki, K.8
-
31
-
-
16444375702
-
Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia
-
Packham, G. Stevenson, F.K. (2005) Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology, 114, 441 449.
-
(2005)
Immunology
, vol.114
, pp. 441-449
-
-
Packham, G.1
Stevenson, F.K.2
-
32
-
-
0034899388
-
Chlorambucil drug resistance in chronic lymphocytic leukemia: The emerging role of DNA repair
-
Panasci, L., Paiement, J.P., Christodoulopoulos, G., Belenkov, A., Malapetsa, A. Aloyz, R. (2001) Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair. Clinical Cancer Research, 7, 454 461.
-
(2001)
Clinical Cancer Research
, vol.7
, pp. 454-461
-
-
Panasci, L.1
Paiement, J.P.2
Christodoulopoulos, G.3
Belenkov, A.4
Malapetsa, A.5
Aloyz, R.6
-
33
-
-
0036255553
-
The role of DNA repair in nitrogen mustard drug resistance
-
Panasci, L., Xu, Z.Y., Bello, V. Aloyz, R. (2002) The role of DNA repair in nitrogen mustard drug resistance. Anti-Cancer Drugs, 13, 211 220.
-
(2002)
Anti-Cancer Drugs
, vol.13
, pp. 211-220
-
-
Panasci, L.1
Xu, Z.Y.2
Bello, V.3
Aloyz, R.4
-
34
-
-
6044254953
-
Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement
-
Rodriguez, A., Martinez, N., Camacho, F.I., Ruiz-Ballesteros, E., Algara, P., Garcia, J.F., Menarguez, J., Alvaro, T., Fresno, M.F., Solano, F., Mollejo, M., Martin, C. Piris, M.A. (2004) Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement. Clinical Cancer Research, 10, 6796 6806.
-
(2004)
Clinical Cancer Research
, vol.10
, pp. 6796-6806
-
-
Rodriguez, A.1
Martinez, N.2
Camacho, F.I.3
Ruiz-Ballesteros, E.4
Algara, P.5
Garcia, J.F.6
Menarguez, J.7
Alvaro, T.8
Fresno, M.F.9
Solano, F.10
Mollejo, M.11
Martin, C.12
Piris, M.A.13
-
35
-
-
4444228658
-
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response
-
Rosenwald, A., Chuang, E.Y., Davis, R.E., Wiestner, A., Alizadeh, A.A., Arthur, D.C., Mitchell, J.B., Marti, G.E., Fowler, D.H., Wilson, W.H. Staudt, L.M. (2004) Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood, 104, 1428 1434.
-
(2004)
Blood
, vol.104
, pp. 1428-1434
-
-
Rosenwald, A.1
Chuang, E.Y.2
Davis, R.E.3
Wiestner, A.4
Alizadeh, A.A.5
Arthur, D.C.6
Mitchell, J.B.7
Marti, G.E.8
Fowler, D.H.9
Wilson, W.H.10
Staudt, L.M.11
-
36
-
-
34548485558
-
The role of DNA repair in chronic lymphocytic leukemia pathogenesis and chemotherapy resistance
-
Sampath, D. Plunkett, A.W. (2007) The role of DNA repair in chronic lymphocytic leukemia pathogenesis and chemotherapy resistance. Current Oncology Reports, 9, 361 367.
-
(2007)
Current Oncology Reports
, vol.9
, pp. 361-367
-
-
Sampath, D.1
Plunkett, A.W.2
-
37
-
-
0025923088
-
Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations
-
Schwartzberg, P.L., Stall, A.M., Hardin, J.D., Bowdish, K.S., Humaran, T., Boast, S., Harbison, M.L., Robertson, E.J. Goff, S.P. (1991) Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell, 65, 1165 1175.
-
(1991)
Cell
, vol.65
, pp. 1165-1175
-
-
Schwartzberg, P.L.1
Stall, A.M.2
Hardin, J.D.3
Bowdish, K.S.4
Humaran, T.5
Boast, S.6
Harbison, M.L.7
Robertson, E.J.8
Goff, S.P.9
-
38
-
-
38049155945
-
Regulation of DNA double-strand break repair pathway choice
-
Shrivastav, M., De Haro, L.P. Nickoloff, J.A. (2008) Regulation of DNA double-strand break repair pathway choice. Cell Research, 18, 134 147.
-
(2008)
Cell Research
, vol.18
, pp. 134-147
-
-
Shrivastav, M.1
De Haro, L.P.2
Nickoloff, J.A.3
-
39
-
-
0034898859
-
C-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination
-
Sionov, R.V., Coen, S., Goldberg, Z., Berger, M., Bercovich, B., Ben-Neriah, Y., Ciechanover, A. Haupt, Y. (2001) c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination. Molecular Cell Biology, 21, 5869 5878.
-
(2001)
Molecular Cell Biology
, vol.21
, pp. 5869-5878
-
-
Sionov, R.V.1
Coen, S.2
Goldberg, Z.3
Berger, M.4
Bercovich, B.5
Ben-Neriah, Y.6
Ciechanover, A.7
Haupt, Y.8
-
40
-
-
0025780879
-
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
-
Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T. Mulligan, R.C. (1991) Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell, 65, 1153 1163.
-
(1991)
Cell
, vol.65
, pp. 1153-1163
-
-
Tybulewicz, V.L.1
Crawford, C.E.2
Jackson, P.K.3
Bronson, R.T.4
Mulligan, R.C.5
-
41
-
-
55949102580
-
Dasatinib pharmacokinetics and exposure-response (E-R): Relationship to safety and efficacy in patients (pts) with chronic myeloid leukemia (CML)
-
May 20 suppl; abstract 3590).
-
Wang, X., Hochhaus, A., Kantarjian, H.M., Agrawal, S., Roy, A., Pfister, M., Chen, T., Bleickardt, E., Nicaise, C. Shah, N. (2008) Dasatinib pharmacokinetics and exposure-response (E-R): Relationship to safety and efficacy in patients (pts) with chronic myeloid leukemia (CML). Journal of Clinical Oncology, 26 May 20 suppl; abstract 3590).
-
(2008)
Journal of Clinical Oncology
, vol.26
-
-
Wang, X.1
Hochhaus, A.2
Kantarjian, H.M.3
Agrawal, S.4
Roy, A.5
Pfister, M.6
Chen, T.7
Bleickardt, E.8
Nicaise, C.9
Shah, N.10
-
42
-
-
0034671627
-
The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19
-
Zipfel, P.A., Grove, M., Blackburn, K., Fujimoto, M., Tedder, T.F. Pendergast, A.M. (2000) The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19. Journal of Immunology, 165, 6872 6879.
-
(2000)
Journal of Immunology
, vol.165
, pp. 6872-6879
-
-
Zipfel, P.A.1
Grove, M.2
Blackburn, K.3
Fujimoto, M.4
Tedder, T.F.5
Pendergast, A.M.6
|